Nkgen Biotech Inc (NKGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2021 | |
| Assets | |
| Current Assets | |
| TOTAL | $N/A |
| Non-Current Assets | |
| Other Non-Current Assets | 280 |
| TOTAL | $280 |
| Total Assets | $280 |
| Liabilities | |
| Current Liabilities | |
| Accounts payable and accrued liabilities | 18 |
| Accrued Expenses | 175 |
| TOTAL | $290 |
| Non-Current Liabilities | |
| TOTAL | $N/A |
| Total Liabilities | $290 |
| Shareholders' Equity | |
| Shares Outstanding, K | 21,452 |
| Retained earnings | -36 |
| TOTAL | $-11 |
| Total Liabilities And Equity | $280 |